CJ CheilJedang is joining hands with the Chinese state-owned enterprise Singhuipin (StarLakeEppen) to expand its lysine business model from simple "production" to "technology exports." The strategy is to diversify its revenue base by going beyond simple product sales to transfer strain and fermentation process technologies and receive royalties.


On the 22nd, CJ CheilJedang announced that it had signed a technology licensing agreement for lysine products with Singhuipin. Under this agreement, CJ CheilJedang will grant exclusive rights to use its lysine strain in China in the form of an exclusive license. Fermentation and strain process optimization technologies accumulated in the global market will thus be combined with a large-scale production base in China. Singhuipin is a global bio-fermentation technology company that produces amino acids, food additives, fertilizers, and more.


Yoon Seokhwan, CEO of CJ CheilJedang (right), and Yan Xiaolin, CEO of Singhuipin, are posing for a commemorative photo after the signing ceremony. Photo by CJ CheilJedang.

Yoon Seokhwan, CEO of CJ CheilJedang (right), and Yan Xiaolin, CEO of Singhuipin, are posing for a commemorative photo after the signing ceremony. Photo by CJ CheilJedang.

View original image

Yoon Seokhwan, CEO of CJ CheilJedang, said at the signing ceremony, "The technological prowess of CJ CheilJedang in lysine and the value of our strains have once again been recognized in the global market," adding, "This collaboration goes beyond a simple technology licensing agreement and is meaningful in that the two companies have together laid a solid foundation for the sustainable growth of the amino acid industry."


The two companies also plan to continue their cooperation in the fields of biotechnology and bio-fermentation technology going forward.


Meanwhile, starting with lysine in 1991, CJ CheilJedang has expanded its green bio product portfolio to include threonine in 2000, tryptophan in 2010, valine in 2014, and methionine in 2015. The company currently has the world's largest feed amino acid portfolio, with a total of eight products, and produces all products on the market using its own fermentation technology.



The global feed amino acid market is generally highly liquid, and its size ranges from as small as several hundred billion won to as large as several trillion won, depending on the product category. In this market, which has become a fiercely contested arena due to aggressive capacity expansions by Chinese companies, CJ CheilJedang maintains the No. 1 market share in products such as tryptophan, arginine, and isoleucine, based on preemptive investments and strong research and development (R&D) capabilities.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing